Kay Wang

1.5k total citations
39 papers, 919 citations indexed

About

Kay Wang is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Kay Wang has authored 39 papers receiving a total of 919 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 20 papers in Pulmonary and Respiratory Medicine and 13 papers in Physiology. Recurrent topics in Kay Wang's work include Pneumonia and Respiratory Infections (13 papers), Respiratory and Cough-Related Research (12 papers) and Asthma and respiratory diseases (11 papers). Kay Wang is often cited by papers focused on Pneumonia and Respiratory Infections (13 papers), Respiratory and Cough-Related Research (12 papers) and Asthma and respiratory diseases (11 papers). Kay Wang collaborates with scholars based in United Kingdom, United States and Belgium. Kay Wang's co-authors include Anthony Harnden, Nia Roberts, Christopher Butler, Oliver van Hecke, Peter J. Gill, Rafael Perera, Sarah Tonkin‐Crine, David Mant, Matthew Shun‐Shin and Carl Heneghan and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Kay Wang

34 papers receiving 905 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kay Wang United Kingdom 18 469 220 211 149 147 39 919
Berna DL Broekhuizen Netherlands 18 448 1.0× 336 1.5× 169 0.8× 138 0.9× 103 0.7× 47 1.1k
Robert J. Rydman United States 24 450 1.0× 182 0.8× 247 1.2× 145 1.0× 279 1.9× 49 2.0k
Jeff Powis Canada 23 929 2.0× 130 0.6× 132 0.6× 59 0.4× 171 1.2× 82 1.6k
Gregory Volturo United States 12 526 1.1× 145 0.7× 332 1.6× 38 0.3× 142 1.0× 28 1.2k
J. Macfarlane United Kingdom 12 454 1.0× 393 1.8× 345 1.6× 81 0.5× 212 1.4× 25 1.0k
Joseph B. Cantey United States 22 812 1.7× 293 1.3× 300 1.4× 92 0.6× 69 0.5× 67 1.7k
Lilliam Ambroggio United States 20 823 1.8× 233 1.1× 60 0.3× 32 0.2× 69 0.5× 98 1.2k
Alberto Capelastegui Spain 25 1.3k 2.8× 551 2.5× 138 0.7× 132 0.9× 123 0.8× 51 1.9k
Malene Plejdrup Hansen Denmark 18 340 0.7× 247 1.1× 464 2.2× 77 0.5× 313 2.1× 64 1.1k
Masahiro Ishikane Japan 16 420 0.9× 83 0.4× 216 1.0× 70 0.5× 100 0.7× 120 1.1k

Countries citing papers authored by Kay Wang

Since Specialization
Citations

This map shows the geographic impact of Kay Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kay Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kay Wang more than expected).

Fields of papers citing papers by Kay Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kay Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kay Wang. The network helps show where Kay Wang may publish in the future.

Co-authorship network of co-authors of Kay Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Kay Wang. A scholar is included among the top collaborators of Kay Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kay Wang. Kay Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morton, Katherine, et al.. (2025). Qualitative insights into planning implementation of FeNO-guided asthma management in primary care. npj Primary Care Respiratory Medicine. 35(1). 16–16.
2.
Tibble, Holly, Andrew Bush, Steve Cunningham, et al.. (2025). Using routine primary care data in research: (in)efficient case studies and perspectives from the Asthma UK Centre for Applied Research. BMJ Health & Care Informatics. 32(1). e101134–e101134.
3.
Wang, Kay, Carol Stonham, Christine Rutherford, & Ian Pavord. (2023). Fractional exhaled nitric oxide (FeNO): the future of asthma care?. British Journal of General Practice. 73(737). 565–568. 6 indexed citations
5.
Little, Paul, Robert C. Read, Taeko Becque, et al.. (2022). Antibiotics for lower respiratory tract infection in children presenting in primary care (ARTIC-PC): the predictive value of molecular testing. Clinical Microbiology and Infection. 28(9). 1238–1244. 2 indexed citations
6.
Wang, Kay, Malcolm G. Semple, Michael Moore, et al.. (2021). The early use of Antibiotics for at Risk CHildren with InfluEnza-like illness (ARCHIE): a double-blind randomised placebo-controlled trial. European Respiratory Journal. 58(4). 2002819–2002819. 5 indexed citations
7.
Hayward, Gail, Jan Y. Verbakel, George Edwards, et al.. (2020). Non-contact infrared versus axillary and tympanic thermometers in children attending primary care: a mixed-methods study of accuracy and acceptability. British Journal of General Practice. 70(693). e236–e244. 17 indexed citations
8.
Bruel, Ann Van den, Jan Y. Verbakel, Kay Wang, et al.. (2020). Non-contact infrared thermometers compared with current approaches in primary care for children aged 5 years and under: a method comparison study. Health Technology Assessment. 24(53). 1–28. 7 indexed citations
9.
Wang, Kay, Jan Y. Verbakel, Jason Oke, et al.. (2020). Using fractional exhaled nitric oxide to guide step-down treatment decisions in patients with asthma: a systematic review and individual patient data meta-analysis. European Respiratory Journal. 55(5). 1902150–1902150. 23 indexed citations
10.
Wang, Kay, Sharon Tonner, Malcolm G. Semple, et al.. (2018). Early use of Antibiotics for at Risk CHildren with InfluEnza (ARCHIE): protocol for a double-blind, randomised, placebo-controlled trial. BMJ Open. 8(5). e021144–e021144. 3 indexed citations
11.
Furuta, Marie, Jacqueline Sin, Edmond S. W. Ng, & Kay Wang. (2017). Efficacy and safety of pertussis vaccination for pregnant women – a systematic review of randomised controlled trials and observational studies. BMC Pregnancy and Childbirth. 17(1). 390–390. 63 indexed citations
12.
Wang, Kay, et al.. (2017). Cough management in primary, secondary and tertiary settings. Pulmonary Pharmacology & Therapeutics. 47. 93–98. 6 indexed citations
13.
Hay, Alastair D, Paul Little, Anthony Harnden, et al.. (2017). Effect of Oral Prednisolone on Symptom Duration and Severity in Nonasthmatic Adults With Acute Lower Respiratory Tract Infection. JAMA. 318(8). 721–721. 33 indexed citations
16.
Gill, Peter J., Helen Ashdown, Kay Wang, et al.. (2014). Identification of children at risk of influenza-related complications in primary and ambulatory care: a systematic review and meta-analysis. The Lancet Respiratory Medicine. 3(2). 139–149. 80 indexed citations
17.
Wang, Kay, Surinder S. Birring, Kathryn Taylor, et al.. (2013). Montelukast for postinfectious cough in adults: a double-blind randomised placebo-controlled trial. The Lancet Respiratory Medicine. 2(1). 35–43. 42 indexed citations
18.
Wang, Kay, Matthew Shun‐Shin, Peter J. Gill, Rafael Perera, & Anthony Harnden. (2012). Neuraminidase inhibitors for preventing and treating influenza in children. Cochrane Database of Systematic Reviews. 34 indexed citations
19.
Wang, Kay, Victoria J. Chalker, Alison Bermingham, et al.. (2011). Mycoplasma pneumoniae and Respiratory Virus Infections in Children With Persistent Cough in England. The Pediatric Infectious Disease Journal. 30(12). 1047–1051. 22 indexed citations
20.
Wang, Kay & Anthony Harnden. (2010). Pertussis-induced cough. Pulmonary Pharmacology & Therapeutics. 24(3). 304–307. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026